275 related articles for article (PubMed ID: 26156649)
1. Deleterious Effect of Radiation Therapy on Epidermodysplasia Verruciformis Patients.
de Oliveira WR; da Cruz Silva LL; Neto CF; Tyring S
J Cutan Med Surg; 2015; 19(4):416-21. PubMed ID: 26156649
[TBL] [Abstract][Full Text] [Related]
2. Development of aggressive squamous cell carcinoma in epidermodysplasia verruciformis associated with human papillomavirus type 22b.
Kim T; Park JC; Roh MR; Park JM; Kim SH; Cho NH; Lee MG
Dermatology; 2010; 220(4):326-8. PubMed ID: 20460877
[TBL] [Abstract][Full Text] [Related]
3. Epidermodysplasia verruciformis.
Burger B; Itin PH
Curr Probl Dermatol; 2014; 45():123-31. PubMed ID: 24643182
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of p16 protein expression in squamous cell carcinomas from patients with epidermodysplasia verruciformis and patients without the disease.
Mattos MSG; Oliveira WR; Sotto MN
Arch Dermatol Res; 2017 Aug; 309(6):479-483. PubMed ID: 28439661
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus and squamous cell cancer of the skin--epidermodysplasia verruciformis-associated human papillomavirus revisited.
Arnold AW; Hofbauer GF
Curr Probl Dermatol; 2012; 43():49-56. PubMed ID: 22377919
[TBL] [Abstract][Full Text] [Related]
6. Clinical aspects of epidermodysplasia verruciformis and review of the literature.
Gül U; Kiliç A; Gönül M; Cakmak SK; Bayis SS
Int J Dermatol; 2007 Oct; 46(10):1069-72. PubMed ID: 17910717
[TBL] [Abstract][Full Text] [Related]
7. Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin.
Harwood CA; Surentheran T; Sasieni P; Proby CM; Bordea C; Leigh IM; Wojnarowska F; Breuer J; McGregor JM
Br J Dermatol; 2004 May; 150(5):949-57. PubMed ID: 15149508
[TBL] [Abstract][Full Text] [Related]
8. Epidermodysplasia verruciformis after cutaneous T-cell lymphoma: Periungual presentation.
Cutlan JE; Rashid RM; Torres-Cabala C; Tyring SK; Thomas V
Dermatol Online J; 2010 Aug; 16(8):12. PubMed ID: 20804689
[TBL] [Abstract][Full Text] [Related]
9. [Cutaneous squamous cell carcinoma and human papillomavirus].
Corbalán-Vélez R; Ruiz-Maciá JA; Brufau C; Carapeto FJ
Actas Dermosifiliogr; 2007 Nov; 98(9):583-93. PubMed ID: 17961447
[TBL] [Abstract][Full Text] [Related]
10. Cloning of mucosal and cutaneous HPV sequences in a metastatic squamous cell carcinoma from an epidermodysplasia verruciformis patient.
Payne D; Chan TS; Wagner R; Tyring SK
Anticancer Res; 1996; 16(3A):1165-6. PubMed ID: 8702229
[TBL] [Abstract][Full Text] [Related]
11. Detection of new human papillomavirus sequences in skin lesions of a renal transplant recipient and characterization of one complete genome related to epidermodysplasia verruciformis-associated types.
Bens G; Wieland U; Hofmann A; Höpfl R; Pfister H
J Gen Virol; 1998 Apr; 79 ( Pt 4)():779-87. PubMed ID: 9568973
[TBL] [Abstract][Full Text] [Related]
12. Benign and malignant hybrid adnexal tumors in a patient with epidermodysplasia verruciformis.
Ho JD; Kam SA; Al-Haseni A; Markova A; Sahni D; Lam C; Goldberg LJ; Bhawan J
J Cutan Pathol; 2017 Nov; 44(11):969-973. PubMed ID: 28796338
[TBL] [Abstract][Full Text] [Related]
13. Detection of Merkel cell polyomavirus in epidermodysplasia-verruciformis-associated skin neoplasms.
Mertz KD; Schmid M; Burger B; Itin P; Palmedo G; Schärer L; Kutzner H; Fernández Figueras MT; Cribier B; Pfaltz M; Kempf W
Dermatology; 2011 Feb; 222(1):87-92. PubMed ID: 21099200
[TBL] [Abstract][Full Text] [Related]
14. A novel human papillomavirus identified in epidermodysplasia verruciformis.
Harris AJ; Purdie K; Leigh IM; Proby C; Burge S
Br J Dermatol; 1997 Apr; 136(4):587-91. PubMed ID: 9155964
[TBL] [Abstract][Full Text] [Related]
15. Epidermodysplasia verruciformis in a young man with HIV since birth--case report.
Meireles SI; Andrade SM; Lima CL; Pires MC
An Bras Dermatol; 2013; 88(6 Suppl 1):190-2. PubMed ID: 24346916
[TBL] [Abstract][Full Text] [Related]
16. [Epidermodysplasia verruciformis-like cells as histologic markers of immunosuppression: review of 229 squamous cell carcinomas].
Corbalán-Vélez R; Ruiz-Maciá JA; Brufau C; López-Lozano JM; Martínez-Barba E; Martínez-Escribano J; Carapeto FJ
Actas Dermosifiliogr; 2008 May; 99(4):269-74. PubMed ID: 18394402
[TBL] [Abstract][Full Text] [Related]
17. Distinctive distribution of human papillomavirus type 16 and type 20 DNA in the tonsillar and the skin carcinomas of a patient with epidermodysplasia verruciformis.
Ishiji T; Kawase M; Honda M; Niimura M; Yoshimura E; Sata T; Matsukura T
Br J Dermatol; 2000 Nov; 143(5):1005-10. PubMed ID: 11069510
[TBL] [Abstract][Full Text] [Related]
18. Seroreactivity to epidermodysplasia verruciformis-related human papillomavirus types is associated with nonmelanoma skin cancer.
Feltkamp MC; Broer R; di Summa FM; Struijk L; van der Meijden E; Verlaan BP; Westendorp RG; ter Schegget J; Spaan WJ; Bouwes Bavinck JN
Cancer Res; 2003 May; 63(10):2695-700. PubMed ID: 12750299
[TBL] [Abstract][Full Text] [Related]
19. The presence of antibodies against virus-like particles of epidermodysplasia verruciformis-associated humanpapillomavirus type 8 in patients with actinic keratoses.
Bouwes Bavinck JN; Stark S; Petridis AK; Marugg ME; Ter Schegget J; Westendorp RG; Fuchs PG; Vermeer BJ; Pfister H
Br J Dermatol; 2000 Jan; 142(1):103-9. PubMed ID: 10651702
[TBL] [Abstract][Full Text] [Related]
20. Epidermodysplasia verruciformis: clinical presentation with varied forms of lesions.
Sá NB; Guerini MB; Barbato MT; Di Giunta G; Nunes DH
An Bras Dermatol; 2011; 86(4 Suppl 1):S57-60. PubMed ID: 22068772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]